Editorial: Chronic insomnia: treatment and management
Frontiers in Neurology · 17.11.2026 · 17
DOI: 10.3389/fneur.2026.1837101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Neurology, online erschienen am 17.11.2026. Verfasst von Kittisak Sawanyawisuth und 2 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Schlaf
Abstract (Originalsprache)
There were 11 articles in this category, comprising acupuncture-related articles (7 articles) and non-acupuncture-related articles (4 articles). The acupuncture-related articles consisted of 3 systematic reviews, while the other four articles were study protocols. The non-acupuncture-related articles focused on herbal medicines, aromatherapy, and mindfulness therapy.For the acupuncture-related articles, a systematic review of randomized controlled trials comparing acupuncture and sham acupuncture was conducted by searching eight databases for articles published up to March 17, 2025 (13). There were 10 eligible studies involving 757 patients with chronic insomnia. The study analysis found that acupuncture resulted in significantly better Pittsburgh Sleep Quality Index (PSQI) and Insomnia Severity Index (ISI) scores than sham acupuncture, with a mean difference of -2.60 (p < 0.00001) and -2.04 (p = 0.0005), respectively.Another systematic review also reported similar findings (14).Acupuncture yielded significantly lower PSQI scores than sham acupuncture, with a mean difference of -3.55 (p < 0.00001) across 17 included randomized controlled trials. Additionally, this study showed that moderate-and high-session acupuncture yielded significantly greater improvements in PSQI scores than sham acupuncture, with mean differences of -3.02 (p < 0.00001, I 2 = 91%) and -2.14 (p < 0.00001, I 2 = 89%), respectively. Note that the I 2 values for both analyses were extremely high, indicating high heterogeneity. Conversely, the low-session group did not have significantly better PSQI scores than the sham acupuncture group, with a mean difference of -1.44 (p = 0.08, I2 = 90%). The I 2 was still high in this comparison; therefore, these results should be interpreted cautiously.The last systematic review was conducted to evaluate the effects of acupuncture on the brain in patients with primary insomnia based on a search of seven databases (15). The review included randomized controlled trials comparing patients with primary insomnia and healthy controls across 11 studies using functional magnetic resonance imaging. The main results showed that acupuncture significantly improved the function of eight brain areas, including the right superior frontal gyrus (1,404 voxels, p = 0.0123), left inferior frontal gyrus (1,068 voxels, p = 0.0088), left inferior temporal gyrus (903 voxels, p = 0.0074), left supramarginal gyrus (888 voxels, p = 0.0113), left precuneus (457 voxels, p = 0.0247), right precuneus (302 voxels, p = 0.0191), left supplementary motor area (82 voxels, p = 0.0354), and right parahippocampal gyrus (28 voxels, p = 0.0379).showing that: 1) acupuncture exerts a regulatory influence on the functional activity of brain regions implicated in cognitive and emotional processes, and 2) acupuncture affects metabolite levels and circadian clock gene expression, and enhances both inflammatory responses and energy metabolism (16). However, there is limited data on this aspect. Further clinical trials and basic research are needed to confirm the mechanisms of acupuncture on the brain in human subjects with insomnia.Finally, the three study protocols for upcoming randomized controlled trials were: 1) Brain function assessment of acupuncture for chronic insomnia disorder with mild cognitive dysfunction based on functional near-infrared spectroscopy; 2) Efficacy of electroacupuncture treatment for generalized anxiety disorder-related insomnia; and 3) Dose-effect relationship of different acupuncture courses on chronic insomnia disorder (17)(18)(19). These three study protocols present notable approaches, and their findings could significantly contribute to the comprehension of the brain mechanisms underlying acupuncture.The four non-acupuncture-related articles focused on Suanzaoren decoction (1 article), a systematic review of aromatherapy (1 article), a randomized controlled trial of mindfulnessbased cognitive therapy (1 article), and a study protocol for long-snake moxibustion (1 article).The first study compared Suanzaoren decoction with estazolam in the treatment of chronic insomnia in adults (20). A total of 80 patients were included, with 51 patients receiving Suanzaoren decoction and 29 patients receiving estazolam. The efficacy of both medications was comparable, with effective rates of 78.40% and 72.40%, respectively (p = 0.543).The second study was a systematic review of five databases that included randomized controlled trials comparing aromatherapy to a control for the treatment of comorbid insomnia (21). The review included 27 articles comprising 2,072 patients in total. The authors found that inhalation aromatherapy improved symptoms of insomnia, anxiety, and depression more effectively than the control, with mean differences of -2.90 (p < 0.00001), -3.97 (p < 0.0001), and -9.58 (p = 0.0007), respectively. The authors concluded that inhalation aromatherapy significantly improved sleep quality compared to the control in patients with comorbid insomnia. Notably, there were no serious adverse reactions reported in the study.The third study was conducted in Norway and explored insomnia symptoms in patients with recurrent depression (22). The authors enrolled 68 patients with at least three episodes of depression and divided them into two groups; ultimately, 55 patients completed the study: 25 in the mindfulness-based cognitive therapy (MBCT) group and 30 in the control group. After 8 weeks of treatment, the MBCT group had less severe insomnia symptoms (p = 0.017), shorter sleep onset (p = 0.047), and fewer nocturnal awakenings (p = 0.023) than the control group. However, there were no significant differences regarding early morning awakening, daytime impairment, or dissatisfaction with sleep. In other words, MBCT may improve specific insomnia symptoms in patients with recurrent depression. Finally, the study protocol in this category is entitled "Efficacy and Mechanism of Long-Snake Moxibustion for Treating Insomnia in Breast Cancer Survivors" (23).These articles show the potential benefits of alternative medicine and cognitive therapy for insomnia. However, due to the limited number of studies and small sample sizes, further clinical studies are needed to confirm these findings.There were three articles in this category. The first is a review of gut microbiota and insomnia after COVID-19 infection (24). This review by Fang et al. showed that COVID-19 infection caused widespread and long-lasting changes to the gut microbiota by reducing beneficial flora and increasing harmful pathogens. These changes may be related to insomnia in patients who have recovered from a COVID-19 infection. Additionally, the authors discussed potential treatments for insomnia after COVID-19 infection through gut microbiota regulation, such as probiotics, prebiotics, or synbiotics.The second study was conducted by Yang et al. from China (25). The authors used a twosample Mendelian randomization analysis based on genome-wide association data to evaluate the association between gut microbiota and insomnia. They identified four gut microbial taxa related to insomnia, acting as either risk factors or protective factors. The family Ruminococcaceae and the genus Lachnospiraceae were two risk factors for insomnia, with odds ratios of 1.497 (p = 0.047) and 1.726 (p = 0.004), respectively. The genus Flavonifractor and the genus Olsenella were significant protective factors against insomnia, with odds ratios of 0.596 (p = 0.030) and 0.808 (p = 0.031), respectively. The authors proposed two major implications for their findings: 1) the potential to use gut microbiota as an objective diagnostic tool and potential treatment target for insomnia; and 2) unlike observational studies, the Mendelian randomization method can control for confounding factors.However, further clinical studies are needed to confirm the results of this study and explore gut microbiota-based treatments for insomnia.The third article analyzed whether any key genes could serve as biomarkers in patients with sleep deprivation compared with healthy human controls (26). The authors found a total of 50 differentially expressed genes, which were divided into two groups: six upregulated genes and 44 downregulated genes. Based on machine learning, five genes were identified as key genes for sleep deprivation: C2CD2L, SPINT2, APOL3, PKNOX1, and A2M. However, only the C2CD2L gene was confirmed by both the qRT-PCR method and machine learning.In summary, there is emerging data regarding the role of gut microbiota and specific genes in chronic insomnia, as demonstrated by Mendelian randomization analysis, machine learning, and PCR methods. However, further studies in this area are still needed.This category includes two subcategories: clinical assessment articles (comprising two studies) and research on three specific populations-patients with obstructive sleep apnea (OSA), adolescents, and adults diagnosed with attention deficit hyperactivity d isorder (ADHD).The first study, by Ayabe et al. from Japan, developed a self-reported quality of life scale for patients with insomnia, known as the QOL-I ( 27). The QOL-I consisted of 11 items, which were tested in 93 adult patients with chronic insomnia and 228 healthy participants. The QOL-I demonstrated high reliability with a Cronbach's alpha of 0.92 and significant criterion-related validity (p < 0.001).The second study from Korea evaluated insomnia treatment practices using data from the Korea National Health Insurance Service-National Sample Cohort (NHIS-NSC) from 2002 to 2019 (28). Interestingly, the authors found that pharmacological treatment was the most common intervention (89.9%), rather than Cognitive Behavioral Therapy (CBT), which should be the first-line treatment. Zolpidem and benzodiazepines were the two most commonly prescribed hypnotics, accounting for 60% and up to 40% of prescriptions, respectively The third article was conducted by Gabryelska et al. from Poland (29). The 127 patients with OSA were categorized into four groups as follows: insomnia with sleepiness (20 patients; 15.75%), sleepiness (22 patients; 17.32%), insomnia (30 patients; 23.62%), and asymptomatic (55 patients; 43.31%). In patients with OSA, the Beck Depression Inventory (BDI) was positively associated with the Epworth Sleepiness Scale (r = 0.205; p = 0.021), Insomnia Severity Index (ISI) (r = 0.578; p < 0.001), Pittsburgh Sleep Quality Index (PSQI) item 2 (subjective sleep latency) (r = 0.199; p = 0.025), and the subjective-to-objective sleep latency ratio (r = 0.208; p = 0.019). Additionally, the BDI was negatively associated with PSQI item 4 (total sleep time) (r = -0.203; p = 0.022). The authors found that the ISI was significantly associated with both mild and moderate depression in patients with OSA. The adjusted odds ratio of the ISI for mild depression was 1.23 (95% confidence interval [CI]: 1.09, 1.38; p < 0.001), while the adjusted odds ratio of the ISI for moderate depression was 1.39 (95% CI: 1.13, 1.72; p = 0.002). Patients with OSA who have a high ISI score may represent a specific phenotype of depression in this setting.The fourth article by Gao et al. from China demonstrated an increasing trend in research on adolescent insomnia using a bibliometric analysis of the Web of Science Core Collection (WoSCC) database between 2002 and 2022 (30). The authors found that there were 2,468 publications on adolescent insomnia. These publications originated from 3,102 institutions across 87 countries, primarily from China and the USA. This study emphasized the growing importance of adolescent insomnia research.The final article evaluated physical activity and sleep in adult patients with ADHD using the National Health and Nutrition Examination Survey (NHANES) database between 2013 and 2020 (pre-COVID pandemic) (31). The authors found that there were 162 eligible adult patients with ADHD who reported using stimulant medicines. Those who engaged in moderate to vigorous physical activity for 150 minutes per week had a lower risk of trouble sleeping, with an odds ratio of 0.26 (95% CI: 0.10, 0.67; p = 0.006). These findings were observed in men, but not in women. This study highlights the importance of physical activity in adult patients with ADHD who use stimulants. However, further research on the treatment and management of chronic insomnia is required to fully understand the underlying mechanisms and clinical outcomes of these various approaches.
Zitieren
APA
Sawanyawisuth, K., Jamil, S. M., & Lipford, M. C. (2026). Editorial: Chronic insomnia: treatment and management. Frontiers in Neurology, 17. https://doi.org/10.3389/fneur.2026.1837101
Vancouver
Sawanyawisuth K, Jamil SM, Lipford MC. Editorial: Chronic insomnia: treatment and management. Frontiers in Neurology. 2026;17. doi:10.3389/fneur.2026.1837101
BibTeX
@article{Sawanyawisuth2026,
author = {Sawanyawisuth, Kittisak and Jamil, Shazia M. and Lipford, Melissa C.},
title = {Editorial: Chronic insomnia: treatment and management},
journal = {Frontiers in Neurology},
year = {2026},
volume = {17},
doi = {10.3389/fneur.2026.1837101}
}
EUVIMED